Clinical Trials in Houston

Showing 9541-9560 of 13,620 trials

Phase I Trial of Oral PX-866

NCT00726583

This study is being conducted to determine the safety and maximally tolerated dose of PX-866 when given orally on two different schedules: daily on days 1-5 and 8-12 of a 28 day cycle and daily on days 1-28 of a 28 day cycle.

Advanced Solid Tumors

Cascadian Therapeutics Inc.90 participantsStarted Jun 2008

Aurora, Colorado, United States • Houston, Texas, United States

COMPLETEDNA< 1 mile

Neurostimulation for the Relief of Acute Bronchoconstriction

NCT00762931

The goal of this study is to validate design for the Resolve™ Stimulator and Proximity Electrode and the associated procedure to quickly and safely place an electrode into the neck, in the vicinity of the vagus nerve by a physician in either the Emergency Department or other appropriate hospital inpatient setting (e.g., ICU). The secondary goal is to confirm that the electrical signal being delivered via this electrode rapidly counters bronchoconstriction and improves airway flow.

Asthma

ElectroCore INC25 participantsStarted Sep 2008

Chicago, Illinois, United States • Detroit, Michigan, United States • Royal Oak, Michigan, United States +3 more locations

COMPLETEDPhase 2< 1 mile

Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy

NCT01240759

The purpose of this study is to evaluate the safety and efficacy of S-707106 co-administered with metformin in subjects with type 2 diabetes mellitus.

Type 2 Diabetes Mellitus

Shionogi218 participantsStarted Oct 2010

Houston, Texas, United States

Phase I Trial of Oral PX-866

Neurostimulation for the Relief of Acute Bronchoconstriction

Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy

Find Trials by Condition in Houston

Motivational Incentives to Reduce Secondhand Smoke in NICU Infants' Homes

A Study in Participants With Rheumatoid Arthritis

Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Substance Abuse Treatment to HIV Care (SAT2HIV): The Motivational Interviewing-based Brief Intervention Experiment

Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I

Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation

Phase 1 and 2 Study of PX-866 and Cetuximab

A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection

PF-00489791 For The Treatment Of Raynaud's

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme

Radiosurgery or Open Surgery for Epilepsy Trial

Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer

Co-administration of Meningococcal Vaccine GSK134612 and Pneumococcal Vaccine GSK1024850A vs Individual Administration

A Prospective, Multicenter All Comers Study of Phasix Mesh for Ventral or Incisional Hernia Repair

The Impact of Vitamin D on Disease Activity in Crohn's Disease